PARP12: Poly(ADP-Ribose) Polymerase Family Member 12

A mono-ADP-ribosyltransferase involved in stress granule assembly, antiviral immunity, and cellular stress responses.

Gene Information Card

Symbol PARP12
Full Name Poly(ADP-ribose) polymerase family member 12
Gene Type Protein coding
Chromosomal Location 7q34
NCBI Gene ID 64761 ncbi.nlm.nih.gov/gene/64761
Ensembl ID ENSG00000106031
UniProt ID Q9H0J9
OMIM ID 618083
HGNC ID 26319
Aliases ARTD12, ZC3HDC1, ZAP

Description

PARP12 (poly(ADP-ribose) polymerase family member 12) encodes a mono-ADP-ribosyltransferase that catalyzes the transfer of ADP-ribose from NAD+ to target proteins. It contains a C2H2-type zinc finger domain and a WWE domain, and localizes to cytoplasmic stress granules. PARP12 plays a role in antiviral innate immunity by inhibiting viral replication, and is involved in cellular stress responses, RNA metabolism, and regulation of translation. It is also implicated in cancer biology through its expression in various tumors.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Overexpression of PARP12 in breast cancer cells may promote tumor growth through modulation of stress granule dynamics and RNA metabolism. NCBI Gene, COSMIC
Ovarian cancer PARP12 expression is altered in ovarian cancer; potential role in DNA damage repair and chemoresistance. COSMIC, ClinVar
Viral infections (e.g., Influenza A, HIV-1) PARP12 restricts viral replication by ADP-ribosylating viral proteins and promoting stress granule formation. UniProt, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 12.5 Medium
Spleen 10.2 Medium
Lung 8.7 Medium
Testis 7.3 Low
Brain 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 Cervical cancer cell line; high expression
A549 11.8 Lung carcinoma cell line; moderate expression
MCF7 9.2 Breast cancer cell line; moderate expression
HEK293 6.5 Embryonic kidney cell line; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1123C>T (p.Arg375Trp) Missense 0.02% (gnomAD) Unknown; located in WWE domain, may affect protein-protein interactions
c.1450G>A (p.Glu484Lys) Missense 0.01% (gnomAD) Unknown; located in catalytic domain, potential loss of ADP-ribosyltransferase activity
c.1789_1790insA (p.Thr597AsnfsTer5) Frameshift Rare Loss of function; truncation of C-terminal region
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the catalytic domain or disrupt zinc finger motifs lead to loss of ADP-ribosyltransferase activity and impaired stress granule localization.

Gain of Function (GOF)

No well-characterized gain-of-function mutations have been reported for PARP12.

Dominant Negative (DN)

Missense mutations in the WWE domain may interfere with dimerization or substrate recognition, potentially acting in a dominant-negative manner.

Pathways

ADP-ribosylation (Reactome: R-HSA-201681)
Innate Immune System (Reactome: R-HSA-168249)
Cellular responses to stress (Reactome: R-HSA-2262752)

Protein Summary

PARP12 is a 701-amino acid mono-ADP-ribosyltransferase that localizes to cytoplasmic stress granules. It contains an N-terminal C2H2 zinc finger domain, a central WWE domain, and a C-terminal catalytic ART domain. The protein modifies target proteins by transferring ADP-ribose from NAD+, regulating RNA metabolism, translation, and antiviral responses. PARP12 is expressed in immune tissues and is upregulated in response to interferon and cellular stress. Its activity is critical for restricting viral replication and modulating stress granule dynamics.

Related Products

Product name Cat.No. Species Gene ID
PARP12 Knockout HEK293 Cell Line EDJ-KQ14685 Human 64761 Details Get a Quote
PARP12 Knockout A-549 Cell Line EDJ-KQ44984 Human 64761 Details Get a Quote
PARP12 Knockout HCT 116 Cell Line EDJ-KQ44985 Human 64761 Details Get a Quote
PARP12 Knockout HeLa Cell Line EDJ-KQ44986 Human 64761 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: